nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamoxifen—CYP1A1—chronic obstructive pulmonary disease	0.179	0.509	CbGaD
Tamoxifen—CYP1A2—chronic obstructive pulmonary disease	0.173	0.491	CbGaD
Tamoxifen—CYP2A6—Arformoterol—chronic obstructive pulmonary disease	0.0457	0.117	CbGbCtD
Tamoxifen—CYP2A6—Formoterol—chronic obstructive pulmonary disease	0.0457	0.117	CbGbCtD
Tamoxifen—CYP2A6—Montelukast—chronic obstructive pulmonary disease	0.0347	0.0887	CbGbCtD
Tamoxifen—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.0257	0.0657	CbGbCtD
Tamoxifen—CYP2A6—Prednisolone—chronic obstructive pulmonary disease	0.0203	0.052	CbGbCtD
Tamoxifen—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0189	0.0484	CbGbCtD
Tamoxifen—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0189	0.0484	CbGbCtD
Tamoxifen—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0171	0.0437	CbGbCtD
Tamoxifen—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0157	0.0402	CbGbCtD
Tamoxifen—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0157	0.0402	CbGbCtD
Tamoxifen—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0148	0.038	CbGbCtD
Tamoxifen—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0144	0.0368	CbGbCtD
Tamoxifen—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0144	0.0368	CbGbCtD
Tamoxifen—FMO3—sweat—chronic obstructive pulmonary disease	0.0134	0.27	CbGeAlD
Tamoxifen—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0128	0.0328	CbGbCtD
Tamoxifen—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0121	0.0309	CbGbCtD
Tamoxifen—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0119	0.0305	CbGbCtD
Tamoxifen—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.00815	0.0209	CbGbCtD
Tamoxifen—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.00794	0.0203	CbGbCtD
Tamoxifen—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.00778	0.0199	CbGbCtD
Tamoxifen—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.00693	0.0177	CbGbCtD
Tamoxifen—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.00679	0.0174	CbGbCtD
Tamoxifen—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.00641	0.0164	CbGbCtD
Tamoxifen—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00407	0.0104	CbGbCtD
Tamoxifen—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00384	0.00983	CbGbCtD
Tamoxifen—EBPL—respiratory system—chronic obstructive pulmonary disease	0.00247	0.0496	CbGeAlD
Tamoxifen—UGT1A4—respiratory system—chronic obstructive pulmonary disease	0.00171	0.0344	CbGeAlD
Tamoxifen—SULT1A1—trachea—chronic obstructive pulmonary disease	0.00145	0.0291	CbGeAlD
Tamoxifen—ESRRA—respiratory system—chronic obstructive pulmonary disease	0.00137	0.0276	CbGeAlD
Tamoxifen—EBPL—lung—chronic obstructive pulmonary disease	0.00131	0.0264	CbGeAlD
Tamoxifen—FMO3—respiratory system—chronic obstructive pulmonary disease	0.00121	0.0242	CbGeAlD
Tamoxifen—DHCR7—bronchus—chronic obstructive pulmonary disease	0.00115	0.0231	CbGeAlD
Tamoxifen—ESRRA—bronchus—chronic obstructive pulmonary disease	0.00113	0.0227	CbGeAlD
Tamoxifen—SULT1A1—lung—chronic obstructive pulmonary disease	0.00104	0.0209	CbGeAlD
Tamoxifen—DHCR7—trachea—chronic obstructive pulmonary disease	0.00103	0.0207	CbGeAlD
Tamoxifen—FMO1—trachea—chronic obstructive pulmonary disease	0.00103	0.0207	CbGeAlD
Tamoxifen—ESRRA—trachea—chronic obstructive pulmonary disease	0.00101	0.0204	CbGeAlD
Tamoxifen—FMO3—bronchus—chronic obstructive pulmonary disease	0.000992	0.02	CbGeAlD
Tamoxifen—CES1—respiratory system—chronic obstructive pulmonary disease	0.000952	0.0191	CbGeAlD
Tamoxifen—CES1—connective tissue—chronic obstructive pulmonary disease	0.000838	0.0169	CbGeAlD
Tamoxifen—ESR2—respiratory system—chronic obstructive pulmonary disease	0.000824	0.0166	CbGeAlD
Tamoxifen—DHCR7—lung—chronic obstructive pulmonary disease	0.000741	0.0149	CbGeAlD
Tamoxifen—FMO1—lung—chronic obstructive pulmonary disease	0.000741	0.0149	CbGeAlD
Tamoxifen—ESRRA—lung—chronic obstructive pulmonary disease	0.000729	0.0147	CbGeAlD
Tamoxifen—ESR2—connective tissue—chronic obstructive pulmonary disease	0.000725	0.0146	CbGeAlD
Tamoxifen—Levomethadyl Acetate—CHRNA3—chronic obstructive pulmonary disease	0.000703	0.241	CrCbGaD
Tamoxifen—ESR2—smooth muscle tissue—chronic obstructive pulmonary disease	0.000664	0.0133	CbGeAlD
Tamoxifen—FMO3—lung—chronic obstructive pulmonary disease	0.00064	0.0129	CbGeAlD
Tamoxifen—CYP1B1—respiratory system—chronic obstructive pulmonary disease	0.000607	0.0122	CbGeAlD
Tamoxifen—CYP19A1—connective tissue—chronic obstructive pulmonary disease	0.000572	0.0115	CbGeAlD
Tamoxifen—ESR1—respiratory system—chronic obstructive pulmonary disease	0.000564	0.0114	CbGeAlD
Tamoxifen—CYP1B1—connective tissue—chronic obstructive pulmonary disease	0.000534	0.0107	CbGeAlD
Tamoxifen—SIGMAR1—bronchus—chronic obstructive pulmonary disease	0.000525	0.0106	CbGeAlD
Tamoxifen—SIGMAR1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000514	0.0103	CbGeAlD
Tamoxifen—CES1—lung—chronic obstructive pulmonary disease	0.000505	0.0102	CbGeAlD
Tamoxifen—ESR1—connective tissue—chronic obstructive pulmonary disease	0.000497	0.00999	CbGeAlD
Tamoxifen—CYP1B1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000489	0.00983	CbGeAlD
Tamoxifen—SIGMAR1—trachea—chronic obstructive pulmonary disease	0.000472	0.00949	CbGeAlD
Tamoxifen—ESR1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000454	0.00914	CbGeAlD
Tamoxifen—CYP2A6—lung—chronic obstructive pulmonary disease	0.00044	0.00885	CbGeAlD
Tamoxifen—ESR2—lung—chronic obstructive pulmonary disease	0.000438	0.0088	CbGeAlD
Tamoxifen—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.000435	0.00875	CbGeAlD
Tamoxifen—CYP1A1—respiratory system—chronic obstructive pulmonary disease	0.000429	0.00863	CbGeAlD
Tamoxifen—CYP3A5—respiratory system—chronic obstructive pulmonary disease	0.00042	0.00844	CbGeAlD
Tamoxifen—CYP2B6—respiratory system—chronic obstructive pulmonary disease	0.000417	0.00839	CbGeAlD
Tamoxifen—CYP2E1—respiratory system—chronic obstructive pulmonary disease	0.000391	0.00787	CbGeAlD
Tamoxifen—CYP1A1—bronchus—chronic obstructive pulmonary disease	0.000353	0.0071	CbGeAlD
Tamoxifen—CYP2B6—bronchus—chronic obstructive pulmonary disease	0.000343	0.0069	CbGeAlD
Tamoxifen—SIGMAR1—lung—chronic obstructive pulmonary disease	0.000339	0.00682	CbGeAlD
Tamoxifen—CYP1B1—lung—chronic obstructive pulmonary disease	0.000322	0.00648	CbGeAlD
Tamoxifen—CYP1A1—trachea—chronic obstructive pulmonary disease	0.000317	0.00638	CbGeAlD
Tamoxifen—Toremifene—CYP1A1—chronic obstructive pulmonary disease	0.000308	0.106	CrCbGaD
Tamoxifen—ESR1—lung—chronic obstructive pulmonary disease	0.0003	0.00603	CbGeAlD
Tamoxifen—Toremifene—CYP1A2—chronic obstructive pulmonary disease	0.000297	0.102	CrCbGaD
Tamoxifen—Clomifene—CYP1A1—chronic obstructive pulmonary disease	0.000266	0.0914	CrCbGaD
Tamoxifen—Clomifene—CYP1A2—chronic obstructive pulmonary disease	0.000257	0.0881	CrCbGaD
Tamoxifen—Cyclobenzaprine—CYP1A2—chronic obstructive pulmonary disease	0.000257	0.0881	CrCbGaD
Tamoxifen—ABCG2—lung—chronic obstructive pulmonary disease	0.00024	0.00483	CbGeAlD
Tamoxifen—CYP1A2—lung—chronic obstructive pulmonary disease	0.000231	0.00465	CbGeAlD
Tamoxifen—CYP1A1—lung—chronic obstructive pulmonary disease	0.000228	0.00458	CbGeAlD
Tamoxifen—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000223	0.00448	CbGeAlD
Tamoxifen—CYP3A5—lung—chronic obstructive pulmonary disease	0.000223	0.00448	CbGeAlD
Tamoxifen—CYP2B6—lung—chronic obstructive pulmonary disease	0.000221	0.00445	CbGeAlD
Tamoxifen—Cyclobenzaprine—HTR2A—chronic obstructive pulmonary disease	0.000217	0.0744	CrCbGaD
Tamoxifen—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.000212	0.00199	CcSEcCtD
Tamoxifen—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000211	0.00198	CcSEcCtD
Tamoxifen—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000211	0.00198	CcSEcCtD
Tamoxifen—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00021	0.00197	CcSEcCtD
Tamoxifen—Hypercholesterolaemia—Prednisone—chronic obstructive pulmonary disease	0.000209	0.00196	CcSEcCtD
Tamoxifen—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.000208	0.00196	CcSEcCtD
Tamoxifen—CYP2E1—lung—chronic obstructive pulmonary disease	0.000208	0.00418	CbGeAlD
Tamoxifen—Cataract—Prednisone—chronic obstructive pulmonary disease	0.000208	0.00195	CcSEcCtD
Tamoxifen—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000207	0.00195	CcSEcCtD
Tamoxifen—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000207	0.00194	CcSEcCtD
Tamoxifen—Dermatitis bullous—Prednisolone—chronic obstructive pulmonary disease	0.000206	0.00194	CcSEcCtD
Tamoxifen—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000205	0.00192	CcSEcCtD
Tamoxifen—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000203	0.00191	CcSEcCtD
Tamoxifen—Vasculitis—Prednisone—chronic obstructive pulmonary disease	0.000202	0.0019	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000202	0.0019	CcSEcCtD
Tamoxifen—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000201	0.00188	CcSEcCtD
Tamoxifen—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.0002	0.00188	CcSEcCtD
Tamoxifen—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.0002	0.00188	CcSEcCtD
Tamoxifen—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.0002	0.00188	CcSEcCtD
Tamoxifen—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000199	0.00187	CcSEcCtD
Tamoxifen—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000199	0.00187	CcSEcCtD
Tamoxifen—Osteoarthritis—Prednisolone—chronic obstructive pulmonary disease	0.000197	0.00185	CcSEcCtD
Tamoxifen—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000196	0.00184	CcSEcCtD
Tamoxifen—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000195	0.00183	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000192	0.00181	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000192	0.0018	CcSEcCtD
Tamoxifen—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000191	0.0018	CcSEcCtD
Tamoxifen—Cough—Formoterol—chronic obstructive pulmonary disease	0.000191	0.0018	CcSEcCtD
Tamoxifen—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00019	0.00178	CcSEcCtD
Tamoxifen—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000189	0.00178	CcSEcCtD
Tamoxifen—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000189	0.00178	CcSEcCtD
Tamoxifen—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000189	0.00178	CcSEcCtD
Tamoxifen—Skin exfoliation—Prednisone—chronic obstructive pulmonary disease	0.000189	0.00177	CcSEcCtD
Tamoxifen—Cough—Montelukast—chronic obstructive pulmonary disease	0.000188	0.00176	CcSEcCtD
Tamoxifen—Fluid retention—Prednisone—chronic obstructive pulmonary disease	0.000188	0.00176	CcSEcCtD
Tamoxifen—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.000187	0.00176	CcSEcCtD
Tamoxifen—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000187	0.00176	CcSEcCtD
Tamoxifen—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000187	0.00175	CcSEcCtD
Tamoxifen—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000187	0.00175	CcSEcCtD
Tamoxifen—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000187	0.00175	CcSEcCtD
Tamoxifen—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000187	0.00175	CcSEcCtD
Tamoxifen—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000187	0.00175	CcSEcCtD
Tamoxifen—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000187	0.00175	CcSEcCtD
Tamoxifen—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000186	0.00175	CcSEcCtD
Tamoxifen—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000186	0.00175	CcSEcCtD
Tamoxifen—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000186	0.00175	CcSEcCtD
Tamoxifen—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000185	0.00173	CcSEcCtD
Tamoxifen—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000185	0.00173	CcSEcCtD
Tamoxifen—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000183	0.00172	CcSEcCtD
Tamoxifen—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000183	0.00172	CcSEcCtD
Tamoxifen—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000183	0.00172	CcSEcCtD
Tamoxifen—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000183	0.00172	CcSEcCtD
Tamoxifen—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000182	0.00171	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000181	0.0017	CcSEcCtD
Tamoxifen—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000181	0.0017	CcSEcCtD
Tamoxifen—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000179	0.00168	CcSEcCtD
Tamoxifen—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000179	0.00168	CcSEcCtD
Tamoxifen—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000179	0.00168	CcSEcCtD
Tamoxifen—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000178	0.00167	CcSEcCtD
Tamoxifen—Infection—Formoterol—chronic obstructive pulmonary disease	0.000178	0.00167	CcSEcCtD
Tamoxifen—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000176	0.00166	CcSEcCtD
Tamoxifen—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000176	0.00166	CcSEcCtD
Tamoxifen—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000176	0.00166	CcSEcCtD
Tamoxifen—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000176	0.00166	CcSEcCtD
Tamoxifen—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000176	0.00165	CcSEcCtD
Tamoxifen—Phenoxybenzamine—ADRB2—chronic obstructive pulmonary disease	0.000176	0.0603	CrCbGaD
Tamoxifen—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000175	0.00165	CcSEcCtD
Tamoxifen—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000175	0.00165	CcSEcCtD
Tamoxifen—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000174	0.00164	CcSEcCtD
Tamoxifen—Infection—Montelukast—chronic obstructive pulmonary disease	0.000174	0.00164	CcSEcCtD
Tamoxifen—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000173	0.00163	CcSEcCtD
Tamoxifen—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000173	0.00162	CcSEcCtD
Tamoxifen—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000172	0.00161	CcSEcCtD
Tamoxifen—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000171	0.00161	CcSEcCtD
Tamoxifen—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000169	0.00159	CcSEcCtD
Tamoxifen—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000168	0.00158	CcSEcCtD
Tamoxifen—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000167	0.00157	CcSEcCtD
Tamoxifen—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000166	0.00156	CcSEcCtD
Tamoxifen—ABCB1—trachea—chronic obstructive pulmonary disease	0.000165	0.00331	CbGeAlD
Tamoxifen—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000163	0.00154	CcSEcCtD
Tamoxifen—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000163	0.00154	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000163	0.00153	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000163	0.00153	CcSEcCtD
Tamoxifen—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000162	0.00152	CcSEcCtD
Tamoxifen—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000162	0.00152	CcSEcCtD
Tamoxifen—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000161	0.00151	CcSEcCtD
Tamoxifen—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000161	0.00151	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00016	0.0015	CcSEcCtD
Tamoxifen—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00016	0.0015	CcSEcCtD
Tamoxifen—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00016	0.0015	CcSEcCtD
Tamoxifen—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000159	0.00149	CcSEcCtD
Tamoxifen—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000158	0.00148	CcSEcCtD
Tamoxifen—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000158	0.00148	CcSEcCtD
Tamoxifen—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000158	0.00148	CcSEcCtD
Tamoxifen—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000157	0.00147	CcSEcCtD
Tamoxifen—Injury—Prednisone—chronic obstructive pulmonary disease	0.000156	0.00147	CcSEcCtD
Tamoxifen—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000156	0.00146	CcSEcCtD
Tamoxifen—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000155	0.00146	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000155	0.00145	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000155	0.00145	CcSEcCtD
Tamoxifen—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000154	0.00145	CcSEcCtD
Tamoxifen—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000154	0.00145	CcSEcCtD
Tamoxifen—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000154	0.00145	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000154	0.00145	CcSEcCtD
Tamoxifen—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000153	0.00144	CcSEcCtD
Tamoxifen—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000153	0.00144	CcSEcCtD
Tamoxifen—Pain—Formoterol—chronic obstructive pulmonary disease	0.000153	0.00144	CcSEcCtD
Tamoxifen—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000153	0.00144	CcSEcCtD
Tamoxifen—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.00144	CcSEcCtD
Tamoxifen—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.00143	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000151	0.00142	CcSEcCtD
Tamoxifen—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000151	0.00142	CcSEcCtD
Tamoxifen—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000151	0.00142	CcSEcCtD
Tamoxifen—Pain—Montelukast—chronic obstructive pulmonary disease	0.00015	0.00141	CcSEcCtD
Tamoxifen—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.00015	0.00141	CcSEcCtD
Tamoxifen—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00015	0.0014	CcSEcCtD
Tamoxifen—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000149	0.0014	CcSEcCtD
Tamoxifen—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.0014	CcSEcCtD
Tamoxifen—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000148	0.00139	CcSEcCtD
Tamoxifen—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000148	0.00139	CcSEcCtD
Tamoxifen—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000147	0.00138	CcSEcCtD
Tamoxifen—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000147	0.00138	CcSEcCtD
Tamoxifen—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000147	0.00138	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000146	0.00138	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000146	0.00138	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.00137	CcSEcCtD
Tamoxifen—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.00137	CcSEcCtD
Tamoxifen—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000145	0.00136	CcSEcCtD
Tamoxifen—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000145	0.00136	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000143	0.00135	CcSEcCtD
Tamoxifen—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000143	0.00135	CcSEcCtD
Tamoxifen—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000142	0.00134	CcSEcCtD
Tamoxifen—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000142	0.00134	CcSEcCtD
Tamoxifen—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000142	0.00133	CcSEcCtD
Tamoxifen—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000142	0.00133	CcSEcCtD
Tamoxifen—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000141	0.00132	CcSEcCtD
Tamoxifen—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00014	0.00131	CcSEcCtD
Tamoxifen—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00014	0.00131	CcSEcCtD
Tamoxifen—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00014	0.00131	CcSEcCtD
Tamoxifen—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000139	0.00131	CcSEcCtD
Tamoxifen—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000139	0.00131	CcSEcCtD
Tamoxifen—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000139	0.0013	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000138	0.0013	CcSEcCtD
Tamoxifen—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000137	0.00129	CcSEcCtD
Tamoxifen—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000137	0.00128	CcSEcCtD
Tamoxifen—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000136	0.00128	CcSEcCtD
Tamoxifen—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000134	0.00126	CcSEcCtD
Tamoxifen—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000134	0.00126	CcSEcCtD
Tamoxifen—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000132	0.00124	CcSEcCtD
Tamoxifen—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000132	0.00124	CcSEcCtD
Tamoxifen—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000132	0.00124	CcSEcCtD
Tamoxifen—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000132	0.00124	CcSEcCtD
Tamoxifen—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000129	0.00121	CcSEcCtD
Tamoxifen—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000128	0.00121	CcSEcCtD
Tamoxifen—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000128	0.00121	CcSEcCtD
Tamoxifen—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000127	0.00119	CcSEcCtD
Tamoxifen—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000127	0.00119	CcSEcCtD
Tamoxifen—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000126	0.00119	CcSEcCtD
Tamoxifen—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000126	0.00118	CcSEcCtD
Tamoxifen—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000125	0.00117	CcSEcCtD
Tamoxifen—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000124	0.00117	CcSEcCtD
Tamoxifen—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000123	0.00115	CcSEcCtD
Tamoxifen—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000123	0.00115	CcSEcCtD
Tamoxifen—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000122	0.00115	CcSEcCtD
Tamoxifen—Diphenhydramine—CYP1A2—chronic obstructive pulmonary disease	0.000122	0.0418	CrCbGaD
Tamoxifen—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000122	0.00114	CcSEcCtD
Tamoxifen—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000121	0.00114	CcSEcCtD
Tamoxifen—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00012	0.00113	CcSEcCtD
Tamoxifen—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00012	0.00112	CcSEcCtD
Tamoxifen—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000119	0.00112	CcSEcCtD
Tamoxifen—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000118	0.00111	CcSEcCtD
Tamoxifen—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000118	0.00111	CcSEcCtD
Tamoxifen—ABCB1—lung—chronic obstructive pulmonary disease	0.000118	0.00238	CbGeAlD
Tamoxifen—Methadone—CYP1A2—chronic obstructive pulmonary disease	0.000118	0.0404	CrCbGaD
Tamoxifen—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000116	0.00109	CcSEcCtD
Tamoxifen—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000116	0.00109	CcSEcCtD
Tamoxifen—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.00109	CcSEcCtD
Tamoxifen—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000114	0.00107	CcSEcCtD
Tamoxifen—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000114	0.00107	CcSEcCtD
Tamoxifen—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000114	0.00107	CcSEcCtD
Tamoxifen—Rash—Formoterol—chronic obstructive pulmonary disease	0.000113	0.00106	CcSEcCtD
Tamoxifen—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000113	0.00106	CcSEcCtD
Tamoxifen—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000113	0.00106	CcSEcCtD
Tamoxifen—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000113	0.00106	CcSEcCtD
Tamoxifen—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000113	0.00106	CcSEcCtD
Tamoxifen—Headache—Formoterol—chronic obstructive pulmonary disease	0.000112	0.00105	CcSEcCtD
Tamoxifen—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000112	0.00105	CcSEcCtD
Tamoxifen—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000112	0.00105	CcSEcCtD
Tamoxifen—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.00105	CcSEcCtD
Tamoxifen—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000112	0.00105	CcSEcCtD
Tamoxifen—Rash—Montelukast—chronic obstructive pulmonary disease	0.000111	0.00104	CcSEcCtD
Tamoxifen—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00011	0.00104	CcSEcCtD
Tamoxifen—Depression—Prednisone—chronic obstructive pulmonary disease	0.00011	0.00103	CcSEcCtD
Tamoxifen—Headache—Montelukast—chronic obstructive pulmonary disease	0.00011	0.00103	CcSEcCtD
Tamoxifen—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000109	0.00102	CcSEcCtD
Tamoxifen—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000109	0.00102	CcSEcCtD
Tamoxifen—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000108	0.00102	CcSEcCtD
Tamoxifen—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000108	0.00101	CcSEcCtD
Tamoxifen—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000107	0.001	CcSEcCtD
Tamoxifen—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000107	0.001	CcSEcCtD
Tamoxifen—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000106	0.000999	CcSEcCtD
Tamoxifen—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000106	0.000999	CcSEcCtD
Tamoxifen—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000106	0.000995	CcSEcCtD
Tamoxifen—Promazine—CYP1A2—chronic obstructive pulmonary disease	0.000105	0.0361	CrCbGaD
Tamoxifen—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000104	0.000978	CcSEcCtD
Tamoxifen—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000103	0.000963	CcSEcCtD
Tamoxifen—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.0001	0.000943	CcSEcCtD
Tamoxifen—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.0001	0.000939	CcSEcCtD
Tamoxifen—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	9.97e-05	0.000936	CcSEcCtD
Tamoxifen—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	9.92e-05	0.000932	CcSEcCtD
Tamoxifen—Oedema—Prednisolone—chronic obstructive pulmonary disease	9.7e-05	0.000911	CcSEcCtD
Tamoxifen—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	9.38e-05	0.00088	CcSEcCtD
Tamoxifen—Flushing—Prednisone—chronic obstructive pulmonary disease	9.21e-05	0.000865	CcSEcCtD
Tamoxifen—Promazine—HTR2A—chronic obstructive pulmonary disease	8.87e-05	0.0304	CrCbGaD
Tamoxifen—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	8.86e-05	0.000832	CcSEcCtD
Tamoxifen—Insomnia—Prednisolone—chronic obstructive pulmonary disease	8.77e-05	0.000824	CcSEcCtD
Tamoxifen—Alopecia—Prednisone—chronic obstructive pulmonary disease	8.77e-05	0.000823	CcSEcCtD
Tamoxifen—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	8.71e-05	0.000818	CcSEcCtD
Tamoxifen—Erythema—Prednisone—chronic obstructive pulmonary disease	8.64e-05	0.000811	CcSEcCtD
Tamoxifen—Pain—Prednisolone—chronic obstructive pulmonary disease	8.29e-05	0.000779	CcSEcCtD
Tamoxifen—Anaemia—Prednisone—chronic obstructive pulmonary disease	7.98e-05	0.00075	CcSEcCtD
Tamoxifen—Angioedema—Prednisone—chronic obstructive pulmonary disease	7.89e-05	0.000741	CcSEcCtD
Tamoxifen—Urticaria—Prednisolone—chronic obstructive pulmonary disease	7.7e-05	0.000724	CcSEcCtD
Tamoxifen—Hypertension—Prednisone—chronic obstructive pulmonary disease	7.46e-05	0.0007	CcSEcCtD
Tamoxifen—Myalgia—Prednisone—chronic obstructive pulmonary disease	7.35e-05	0.00069	CcSEcCtD
Tamoxifen—Arthralgia—Prednisone—chronic obstructive pulmonary disease	7.35e-05	0.00069	CcSEcCtD
Tamoxifen—Anxiety—Prednisone—chronic obstructive pulmonary disease	7.33e-05	0.000688	CcSEcCtD
Tamoxifen—Discomfort—Prednisone—chronic obstructive pulmonary disease	7.26e-05	0.000682	CcSEcCtD
Tamoxifen—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	7.15e-05	0.000671	CcSEcCtD
Tamoxifen—Oedema—Prednisone—chronic obstructive pulmonary disease	7.05e-05	0.000662	CcSEcCtD
Tamoxifen—Infection—Prednisone—chronic obstructive pulmonary disease	7e-05	0.000658	CcSEcCtD
Tamoxifen—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	6.81e-05	0.00064	CcSEcCtD
Tamoxifen—Anorexia—Prednisone—chronic obstructive pulmonary disease	6.72e-05	0.000631	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	6.42e-05	0.000603	CcSEcCtD
Tamoxifen—Dizziness—Prednisolone—chronic obstructive pulmonary disease	6.41e-05	0.000602	CcSEcCtD
Tamoxifen—Insomnia—Prednisone—chronic obstructive pulmonary disease	6.37e-05	0.000599	CcSEcCtD
Tamoxifen—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	6.33e-05	0.000594	CcSEcCtD
Tamoxifen—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	6.2e-05	0.000583	CcSEcCtD
Tamoxifen—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	6.13e-05	0.000575	CcSEcCtD
Tamoxifen—Rash—Prednisolone—chronic obstructive pulmonary disease	6.12e-05	0.000574	CcSEcCtD
Tamoxifen—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	6.11e-05	0.000574	CcSEcCtD
Tamoxifen—Fatigue—Prednisone—chronic obstructive pulmonary disease	6.08e-05	0.000571	CcSEcCtD
Tamoxifen—Headache—Prednisolone—chronic obstructive pulmonary disease	6.08e-05	0.000571	CcSEcCtD
Tamoxifen—Constipation—Prednisone—chronic obstructive pulmonary disease	6.03e-05	0.000566	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	5.76e-05	0.000541	CcSEcCtD
Tamoxifen—Nausea—Prednisolone—chronic obstructive pulmonary disease	5.76e-05	0.000541	CcSEcCtD
Tamoxifen—Urticaria—Prednisone—chronic obstructive pulmonary disease	5.6e-05	0.000526	CcSEcCtD
Tamoxifen—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	5.57e-05	0.000523	CcSEcCtD
Tamoxifen—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	5.19e-05	0.000488	CcSEcCtD
Tamoxifen—Asthenia—Prednisone—chronic obstructive pulmonary disease	5.06e-05	0.000475	CcSEcCtD
Tamoxifen—Pruritus—Prednisone—chronic obstructive pulmonary disease	4.99e-05	0.000468	CcSEcCtD
Tamoxifen—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	4.82e-05	0.000453	CcSEcCtD
Tamoxifen—Dizziness—Prednisone—chronic obstructive pulmonary disease	4.66e-05	0.000438	CcSEcCtD
Tamoxifen—Vomiting—Prednisone—chronic obstructive pulmonary disease	4.48e-05	0.000421	CcSEcCtD
Tamoxifen—Rash—Prednisone—chronic obstructive pulmonary disease	4.44e-05	0.000417	CcSEcCtD
Tamoxifen—Dermatitis—Prednisone—chronic obstructive pulmonary disease	4.44e-05	0.000417	CcSEcCtD
Tamoxifen—Headache—Prednisone—chronic obstructive pulmonary disease	4.42e-05	0.000415	CcSEcCtD
Tamoxifen—Nausea—Prednisone—chronic obstructive pulmonary disease	4.19e-05	0.000393	CcSEcCtD
Tamoxifen—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.31e-05	0.000133	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—GC—chronic obstructive pulmonary disease	1.3e-05	0.000133	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.3e-05	0.000133	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	1.29e-05	0.000131	CbGpPWpGaD
Tamoxifen—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.29e-05	0.000131	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.29e-05	0.000131	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.28e-05	0.00013	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.28e-05	0.00013	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—CTGF—chronic obstructive pulmonary disease	1.25e-05	0.000127	CbGpPWpGaD
Tamoxifen—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.24e-05	0.000126	CbGpPWpGaD
Tamoxifen—ESR1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.24e-05	0.000126	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.23e-05	0.000125	CbGpPWpGaD
Tamoxifen—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.22e-05	0.000124	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.22e-05	0.000124	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.21e-05	0.000123	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.2e-05	0.000122	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	1.2e-05	0.000122	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.19e-05	0.000121	CbGpPWpGaD
Tamoxifen—ESR1—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	1.18e-05	0.00012	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.18e-05	0.00012	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—HDAC2—chronic obstructive pulmonary disease	1.16e-05	0.000118	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.16e-05	0.000118	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.14e-05	0.000116	CbGpPWpGaD
Tamoxifen—ESR2—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	1.13e-05	0.000115	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.11e-05	0.000113	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.11e-05	0.000113	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.1e-05	0.000112	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.1e-05	0.000112	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.09e-05	0.000111	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.09e-05	0.000111	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.08e-05	0.00011	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.08e-05	0.000109	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.07e-05	0.000109	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	1.07e-05	0.000109	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.07e-05	0.000108	CbGpPWpGaD
Tamoxifen—ABCC2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.06e-05	0.000108	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—ALB—chronic obstructive pulmonary disease	1.06e-05	0.000108	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.05e-05	0.000107	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.04e-05	0.000106	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.04e-05	0.000106	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	1.04e-05	0.000106	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.04e-05	0.000106	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.03e-05	0.000105	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	1.03e-05	0.000105	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.01e-05	0.000103	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—NOS3—chronic obstructive pulmonary disease	1.01e-05	0.000103	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.01e-05	0.000103	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1e-05	0.000102	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.99e-06	0.000102	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	9.97e-06	0.000101	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.93e-06	0.000101	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	9.93e-06	0.000101	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	9.82e-06	9.98e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	9.74e-06	9.89e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.69e-06	9.85e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.62e-06	9.78e-05	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.62e-06	9.78e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.57e-06	9.72e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—CTGF—chronic obstructive pulmonary disease	9.5e-06	9.65e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—GCLC—chronic obstructive pulmonary disease	9.46e-06	9.61e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	9.42e-06	9.57e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	9.23e-06	9.38e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	9.21e-06	9.36e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.13e-06	9.28e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.05e-06	9.2e-05	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—ALB—chronic obstructive pulmonary disease	8.87e-06	9.01e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	8.86e-06	9e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.75e-06	8.89e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.68e-06	8.82e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	8.66e-06	8.8e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—CTGF—chronic obstructive pulmonary disease	8.63e-06	8.77e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.55e-06	8.69e-05	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—NOS3—chronic obstructive pulmonary disease	8.48e-06	8.62e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.33e-06	8.47e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	8.32e-06	8.45e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.31e-06	8.44e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.22e-06	8.35e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.02e-06	8.15e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.95e-06	8.08e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	7.95e-06	8.08e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.91e-06	8.04e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	7.91e-06	8.04e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	7.79e-06	7.92e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.74e-06	7.86e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.72e-06	7.84e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.66e-06	7.78e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	7.63e-06	7.75e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	7.56e-06	7.69e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.56e-06	7.68e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.55e-06	7.67e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	7.47e-06	7.59e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	7.46e-06	7.58e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	7.42e-06	7.54e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.37e-06	7.49e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.3e-06	7.42e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.26e-06	7.38e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.24e-06	7.35e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	7.21e-06	7.33e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.2e-06	7.32e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.14e-06	7.25e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.13e-06	7.24e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	7.05e-06	7.16e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—KL—chronic obstructive pulmonary disease	7.03e-06	7.14e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.99e-06	7.1e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	6.96e-06	7.08e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	6.82e-06	6.93e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	6.81e-06	6.92e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.71e-06	6.82e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.65e-06	6.76e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.63e-06	6.74e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.6e-06	6.71e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.57e-06	6.68e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	6.54e-06	6.65e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.54e-06	6.65e-05	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—ALB—chronic obstructive pulmonary disease	6.54e-06	6.65e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.54e-06	6.64e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	6.49e-06	6.59e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	6.46e-06	6.56e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	6.43e-06	6.53e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	6.42e-06	6.53e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.42e-06	6.52e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.36e-06	6.46e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.3e-06	6.41e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.28e-06	6.39e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.27e-06	6.37e-05	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—NOS3—chronic obstructive pulmonary disease	6.26e-06	6.36e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	6.16e-06	6.26e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.09e-06	6.19e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.02e-06	6.12e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.97e-06	6.07e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.92e-06	6.02e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	5.9e-06	5.99e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.83e-06	5.93e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.8e-06	5.89e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.78e-06	5.87e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	5.77e-06	5.86e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.69e-06	5.79e-05	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	5.69e-06	5.78e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	5.63e-06	5.72e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.43e-06	5.52e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.38e-06	5.46e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.37e-06	5.45e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.35e-06	5.44e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.32e-06	5.41e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	5.3e-06	5.39e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.28e-06	5.36e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.27e-06	5.36e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	5.26e-06	5.35e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	5.26e-06	5.34e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.24e-06	5.33e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.23e-06	5.31e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.17e-06	5.25e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.16e-06	5.24e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	5.14e-06	5.22e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.07e-06	5.15e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.99e-06	5.07e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.94e-06	5.02e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—ALB—chronic obstructive pulmonary disease	4.93e-06	5.01e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.92e-06	5e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.9e-06	4.98e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.87e-06	4.95e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.85e-06	4.93e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	4.84e-06	4.92e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.82e-06	4.89e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.81e-06	4.88e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	4.8e-06	4.88e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—ALB—chronic obstructive pulmonary disease	4.75e-06	4.83e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.73e-06	4.81e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.72e-06	4.8e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.72e-06	4.79e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.66e-06	4.74e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.57e-06	4.64e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.56e-06	4.63e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.55e-06	4.62e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.55e-06	4.62e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.54e-06	4.61e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.53e-06	4.6e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	4.49e-06	4.57e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.47e-06	4.54e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.46e-06	4.53e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.42e-06	4.49e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—ALB—chronic obstructive pulmonary disease	4.32e-06	4.39e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	4.28e-06	4.35e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	4.19e-06	4.26e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.16e-06	4.23e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—NOS3—chronic obstructive pulmonary disease	4.13e-06	4.2e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	4.1e-06	4.17e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	4.1e-06	4.16e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.04e-06	4.11e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.99e-06	4.05e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.95e-06	4.01e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.95e-06	4.01e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—ALB—chronic obstructive pulmonary disease	3.93e-06	3.99e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.89e-06	3.96e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—NOS3—chronic obstructive pulmonary disease	3.76e-06	3.82e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.72e-06	3.78e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.72e-06	3.78e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.7e-06	3.76e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.69e-06	3.75e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.67e-06	3.73e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.64e-06	3.69e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.63e-06	3.69e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.53e-06	3.59e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.52e-06	3.58e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.51e-06	3.56e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	3.47e-06	3.52e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.44e-06	3.49e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.42e-06	3.47e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.39e-06	3.44e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.24e-06	3.29e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.21e-06	3.26e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	3.17e-06	3.22e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	3.16e-06	3.22e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.15e-06	3.2e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.13e-06	3.18e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.11e-06	3.16e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	3.1e-06	3.15e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	3.1e-06	3.15e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	3.03e-06	3.08e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.97e-06	3.02e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	2.96e-06	3.01e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—ALB—chronic obstructive pulmonary disease	2.93e-06	2.97e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.92e-06	2.96e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.9e-06	2.94e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.83e-06	2.88e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.8e-06	2.84e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.74e-06	2.79e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	2.68e-06	2.73e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	2.57e-06	2.61e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.55e-06	2.59e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.43e-06	2.47e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.4e-06	2.44e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	2.39e-06	2.43e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	2.34e-06	2.37e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.34e-06	2.37e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.29e-06	2.33e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	2.29e-06	2.33e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.24e-06	2.27e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.23e-06	2.27e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	2.2e-06	2.24e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	2.18e-06	2.22e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.12e-06	2.15e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	2.11e-06	2.14e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	2.09e-06	2.12e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.92e-06	1.95e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	1.87e-06	1.9e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.78e-06	1.81e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.76e-06	1.79e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.44e-06	1.46e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.38e-06	1.4e-05	CbGpPWpGaD
